Aptar Pharma and Macquarie University Advance Inhaled Biologics Research
SYDNEY, Australia — September 25, 2026 Aptar Pharma announced a new three-year research collaboration with Macquarie University supported by...
drug delivery
Advertisement
Sun Pharma Launches Taro-Methylphenidate ER for ADHD
Mumbai, India and Brampton, Ontario, Canada, September 21, 2026 Sun Pharmaceutical Industries Limited (Sun Pharma) has announced the commercial...
Roche Wins EU Approval for Susvimo in Wet AMD
Basel, Switzerland, September 21, 2026 Roche has announced that the European Commission has approved Susvimo® (ranibizumab 100 mg/mL) for...
Aptar Pharma and MGH Advance Nose-to-Brain Drug Delivery
CRYSTAL LAKE, Ill. — September 14, 2026 Aptar Pharma and Massachusetts General Hospital (MGH) announced a research collaboration led...
Nasus Pharma Advances NS002 Toward Pivotal Anaphylaxis Study
TEL AVIV, Israel — September 14, 2026 Nasus Pharma Ltd. announced that the U.S. Food and Drug Administration (FDA)...
Advertisements
Tris Pharma Expands QuilliChew ER With 30-Count Bottle
MONMOUTH JUNCTION, N.J. — September 14, 2026 Tris Pharma, Inc. announced the availability of a new 30-count bottle size...
Aptar Pharma, Aceso Advance Inhaled ASO Therapy
Crystal Lake, Illinois — September 7, 2026 Aptar Pharma announced a collaboration with Aceso Therapeutics to advance development activities...
Eisai and Biogen Launch LEQEMBI IQLIK for Alzheimer’s
Tokyo, Japan and Cambridge, Massachusetts, August 25, 2026 Eisai Co., Ltd. and Biogen Inc. announced that LEQEMBI IQLIK® (lecanemab-irmb)...
UroGen Expands Oncology Pipeline Through IntraGel Deal
PRINCETON, New Jersey, August 20, 2026 UroGen Pharma Ltd. announced a strategic collaboration and investment agreement with IntraGel Therapeutics,...
Vector Science Secures 10-Year cGMP Manufacturing Deal
Mequon, Wisconsin, August 17, 2026 Vector Science and Therapeutics Corp. has entered into an amended and restated exclusive license...
Advertisement
